Literature DB >> 28882462

Successful management of a severe anti-M alloimmunization during pregnancy.

Corinne Hubinont1, Gilda Delens2, Julie Vanalbada De Haan Hettema2, Catherine Lambert3, Christian Debauche4, Jean-Marc Biard2.   

Abstract

We report the successful outcome of a patient with anti-M antibodies with a previous history of severe hemolysis of erythrocytes. Serial plasma exchange from the first trimester combined with ultrasound monitoring of the fetal middle cerebral artery blood velocity was implemented. This management allowed a favorable pregnancy outcome of an infant born by an elective caesarean section at 32 weeks 6/7 with a normal Apgar score at 8/9/10. The other therapeutic alternatives such as intravenous immunoglobulin and in utero fetal blood transfusions are discussed.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-M antibodies; Hemolytic disease of the fetus and newborn; Plasmapheresis

Mesh:

Year:  2017        PMID: 28882462     DOI: 10.1016/j.ejogrb.2017.07.024

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy.

Authors:  Yohei Maki; Junko Ushijima; Seishi Furukawa; Hiroko Inagaki; Hiroyuki Takenouchi; Shouichi Fujimoto; Hiroshi Sameshima
Journal:  Case Rep Obstet Gynecol       Date:  2020-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.